- Filed
- Aug 13, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Diluted | Q2 2025 · Jun 30, 2025 | 1.79M sh |
| Shares Diluted | Q2 2025 · Jun 30, 2025 | 1.79M sh |
| Shares Diluted restated | Q2 2025 · Jun 30, 2024 | 1.52M sh |
| Shares Diluted restated | Q2 2025 · Jun 30, 2024 | 1.52M sh |
| Stock Repurchased | Q2 2025 · Jun 30, 2025 | $27.04K |
| Stock Repurchased | Q2 2025 · Jun 30, 2024 | $37.49K |
| Capex | Q2 2025 · Jun 30, 2025 | $1.37M |
| Capex | Q2 2025 · Jun 30, 2024 | $1.98M |
| Operating Cash Flow | Q2 2025 · Jun 30, 2025 | −$419.92K |
| Operating Cash Flow | Q2 2025 · Jun 30, 2024 | $2.56M |
| Long Term Debt | Q2 2025 · Jun 30, 2025 | $239.06M |
| Long Term Debt | Q2 2025 · Dec 31, 2024 | $247.12M |
| Short Term Debt | Q2 2025 · Jun 30, 2025 | $2.8M |
| Short Term Debt | Q2 2025 · Dec 31, 2024 | $0 |
| Cash And Equivalents | Q2 2025 · Jun 30, 2025 | $13.72M |
| Cash And Equivalents | Q2 2025 · Dec 31, 2024 | $13.77M |
| Stockholders Equity | Q2 2025 · Jun 30, 2025 | $144.52M |
| Stockholders Equity | Q2 2025 · Mar 31, 2025 | $144.62M |
| Stockholders Equity | Q2 2025 · Dec 31, 2024 | $147.22M |
| Stockholders Equity | Q2 2025 · Jun 30, 2024 | $149.09M |
| Stockholders Equity | Q2 2025 · Mar 31, 2024 | $149.13M |
| Stockholders Equity | Q2 2025 · Dec 31, 2023 | $148.98M |
| Current Liabilities | Q2 2025 · Jun 30, 2025 | $65.36M |
| Current Liabilities | Q2 2025 · Dec 31, 2024 | $52.99M |
| Total Liabilities | Q2 2025 · Jun 30, 2025 | $403.51M |
| Total Liabilities | Q2 2025 · Dec 31, 2024 | $401.99M |
| Current Assets | Q2 2025 · Jun 30, 2025 | $72.74M |
| Current Assets | Q2 2025 · Dec 31, 2024 | $69.29M |
| Total Assets | Q2 2025 · Jun 30, 2025 | $548.04M |
| Total Assets | Q2 2025 · Dec 31, 2024 | $549.21M |
| Eps Diluted | Q2 2025 · Jun 30, 2025 | −$0.09 |
| Eps Diluted | Q2 2025 · Jun 30, 2025 | −$1.59 |
| Eps Diluted restated | Q2 2025 · Jun 30, 2024 | −$0.18 |
| Eps Diluted restated | Q2 2025 · Jun 30, 2024 | −$0.18 |
| Eps Basic | Q2 2025 · Jun 30, 2025 | −$0.09 |
| Eps Basic | Q2 2025 · Jun 30, 2025 | −$1.59 |
| Eps Basic restated | Q2 2025 · Jun 30, 2024 | −$0.18 |
| Eps Basic restated | Q2 2025 · Jun 30, 2024 | −$0.18 |
| Sga Expense | Q2 2025 · Jun 30, 2025 | $3.77M |
| Sga Expense | Q2 2025 · Jun 30, 2025 | $7.79M |
| Sga Expense | Q2 2025 · Jun 30, 2024 | $3.88M |
| Sga Expense | Q2 2025 · Jun 30, 2024 | $8.29M |
| Net Income | Q2 2025 · Jun 30, 2025 | −$154.18K |
| Net Income | Q2 2025 · Jun 30, 2025 | −$2.84M |
| Net Income | Q2 2025 · Jun 30, 2024 | −$276.02K |
| Net Income | Q2 2025 · Jun 30, 2024 | −$268.05K |
| Operating Income | Q2 2025 · Jun 30, 2025 | $2.89M |
| Operating Income | Q2 2025 · Jun 30, 2025 | $890.67K |
| Operating Income | Q2 2025 · Jun 30, 2024 | $5.38M |
| Operating Income | Q2 2025 · Jun 30, 2024 | $4.27M |
| Revenue | Q2 2025 · Jun 30, 2025 | $53M |
| Revenue | Q2 2025 · Jun 30, 2025 | $101.91M |
| Revenue | Q2 2025 · Jun 30, 2024 | $60.44M |
| Revenue | Q2 2025 · Jun 30, 2024 | $114.82M |